Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
22 Biopharma Stocks With Breakout Potential in 2012
Seeking Alpha
Tue, 05/22/12 - 11:25 am
Ziopharm
Zalicus
EXACT Sciences
Geron
Lexicon Pharmaceuticals
Nektar
Vical
Celgene
Celsion
ChemoCentryx
Clovis Oncology
Eli Lilly
JNJ
Pfizer
Elan
Biomarin
Biogen Idec
Auxilium
Arqule
Anthera
Acadia
Amicus Therapeutics
Vertex Pharmaceuticals
Wednesday's Bio Pharma Drug Approval And Catalyst Watch List
Seeking Alpha
Wed, 05/2/12 - 11:16 am
Amarin
iBio
Lexicon Pharmaceuticals
MedicNova
20 Biotech Stocks Being Bought Up By Hedge Funds
Seeking Alpha
Sun, 03/25/12 - 11:38 am
Achillion
Amylin
Ariad Pharmaceuticals
Aveo Pharmaceutical
Cell Therapeutics
EXACT Sciences
Idenix
Exelixis
Halozyme
Lexicon Pharmaceuticals
Nektar
Momenta
ONYX Pharmaceuticals
Optimer Pharmaceuticals
PDL Biopharma
Questcor Pharmaceuticals
Santarus
Spectrum Pharmaceuticals
Regeneron
Vivus
Orphan Drug Status for Lexicon Drug
Yahoo/Zacks
Sat, 03/24/12 - 11:22 am
Lexicon Pharmaceuticals
LX1032
carcinoid syndrome
Lexicon Announces Plans for Rights Offering to Stockholders
Yahoo/PR NewsWire
Sat, 11/12/11 - 12:25 pm
Lexicon Pharmaceuticals
Data From Phase 2 Clinical Studies of Telotristat Etiprate in Patients With Carcinoid Syndrome to be Presented at North American Neuroendocrine Tumor Society Meeting
Yahoo/PR NewsWire
Sat, 10/22/11 - 12:12 pm
Telotristat Etiprate
Lexicon Pharmaceuticals
carcinoid syndrome
Biotech Busts And Breakthroughs For September 2011
Forbes
Tue, 10/4/11 - 12:32 pm
Pacific Biosciences
Lexicon Pharmaceuticals
China Pharmaceutical
Momenta
SYNERGY
Caliper Life Sciences
Optimer
MannKind
Pharmasset
Hi-Tech Pharmacal
7 Possible Biotech Takeover Targets
Seeking Alpha
Sun, 09/18/11 - 12:02 pm
Human Genome Sciences
Vertex Pharmaceuticals
Lexicon Pharmaceuticals
Amarin
Exelixis
Dendreon
Acorda Therapeutics
It May Be Time for Amylin and Lilly to Head to Divorce Court
Seeking Alpha
Fri, 05/27/11 - 10:50 am
Eli Lilly
Amylin
restraining order
Alkermes
Bristol-Myers Squibb
Elan
GSK
JNJ
Lexicon Pharmaceuticals
Novo Nordisk
Takeda
Lexicon 1Q loss widens on higher costs
Yahoo/AP
Tue, 05/3/11 - 09:22 am
Lexicon Pharmaceuticals
earnings
Biotech Calendar: Key Dates for May
Seeking Alpha
Mon, 05/2/11 - 12:42 pm
biotech
Columbia Laboratories
KV Pharmaceutical
Dendreon
Vertex Pharmaceuticals
MannKind
Alimera
Merck
NPS Pharmaceuticals
Ironwood
BioMimetic Therapeutics
Lexicon Pharmaceuticals
Avanir
Optimer
JNJ
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Seeking Alpha
Sat, 04/9/11 - 11:02 am
Prolor
Lexicon Pharmaceuticals
Dendreon
Human Genome Sciences
Targacept
Sequenom
Cadence Pharmaceuticals
Savient
ONYX Pharmaceuticals
Amylin
Emergent BioSolutions
XenoPort
Spectrum Pharmaceuticals
Incyte
Amgen
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Amylin
Alnylam
Celldex
Exelixis
Human Genome Sciences
Isis Pharmaceuticals
Lexicon Pharmaceuticals
Neurocrine
Nektar
ONYX Pharmaceuticals
Ziopharm
Seattle Genetics
Lexicon Pharma's 4Q loss widens as costs rise
Yahoo/AP
Thu, 02/24/11 - 11:14 pm
earnings
Lexicon Pharmaceuticals
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
M&A
biotech
Biogen Idec
Human Genome
Seattle Genetics
GSK
Dendreon
Actelion
Biomarin
Exelixis
Vertex Pharmaceuticals
Celgene
Alexion
Shire
InterMune
Lexicon Pharmaceuticals
Savient
Merck KGaA
A Biotech Roller Coaster
Motley Fool
Sat, 01/8/11 - 11:57 am
Lexicon Pharmaceuticals
diabetes
LX4211
Merck
obesity
Amylin
Januvia
Onglyza
Bristol-Myers Squibb
AstraZeneca
Lexicon Pharma shares soar after study reported
Yahoo/AP
Fri, 01/7/11 - 07:18 am
Lexicon Pharmaceuticals
diabetes
LX4211
Lexicon Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Wed, 12/15/10 - 10:31 am
Lexicon Pharmaceuticals
rheumatoid arthritis
LX2931
Four Biotechs Positioned for Strong 2010 Finish
Seeking Alpha
Thu, 12/9/10 - 05:41 pm
Inhibitex
Corcept Therapeutics
Cytokinetics
Lexicon Pharmaceuticals
Key Data Approaching for Lexicon's Mid-Stage Pipeline
Morningstar
Sat, 11/6/10 - 01:08 pm
Lexicon Pharmaceuticals
LX2931
arthritis
LX1032
carcinoid syndrome
LX1031
irritable bowel syndrome
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »